{"id":"W2494177319","doi":"10.1038/ajg.2016.298","title":"A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease","year":2016,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":372,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Placebo; Internal medicine; Clinical endpoint; Adverse effect; Randomized controlled trial; Crohn's disease; Gastroenterology; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007619835,0.0002264697,0.0009669028,0.000181509,0.00003965317,0.00001110134,0.0004247628,0.00002324303,0.00001562751],"category_scores_gemma":[0.0001387538,0.0001133412,0.0002003515,0.00008194553,0.0004036979,0.00001225506,0.0001012848,0.000115882,0.000002246611],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003181834,"about_ca_system_score_gemma":0.0001212151,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001184909,"about_ca_topic_score_gemma":0.00007574272,"domain_scores_codex":[0.9973309,0.001063477,0.0007515071,0.000237504,0.0002765688,0.0003400152],"domain_scores_gemma":[0.9979459,0.00006270249,0.001013178,0.0004197722,0.0003173737,0.0002410432],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8807169,0.001468891,0.1157174,0.000003680047,0.0005209452,0.0001144098,0.00014567,0.0007843515,0.000256505,0.000002004436,0.00003659727,0.0002327192],"study_design_scores_gemma":[0.8618762,0.01295038,0.1245685,0.00003198411,0.0002410077,0.00001535758,0.0001660499,0.00001643388,0.00002804399,0.00001187915,0.000003103142,0.00009096255],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974018,0.00001036239,0.0006782569,0.0003027623,0.00006317619,0.00151362,0.00001885422,0.00000265418,0.000008491345],"genre_scores_gemma":[0.9993498,0.000007673253,0.00007076951,0.0003438308,0.00007333603,0.0001004118,0.000003044514,0.00002575204,0.00002533197],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0188406,"threshold_uncertainty_score":0.4621921,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00722341753072199,"score_gpt":0.2518564556839677,"score_spread":0.2446330381532457,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}